Pacing and clinical electrophysiology : PACE最新文献_第3页

Fascicular/Purkinje Tissue Colocalized With Scar in Cardiomyopathy Patients Undergoing Ventricular Fibrillation Ablation. 在接受心室颤动消融的心肌病患者中存在瘢痕的束状组织/浦肯野组织

Pacing and clinical electrophysiology : PACE Pub Date : 2025-06-02 DOI: 10.1111/pace.15215

Emir Baskovski, Timucin Altin, Omer Akyurek, Turkan Seda Tan, Mahmut EkremCunetoglu, Irem Muge Akbulut, Volkan Kozluca, Nail Burak Ozbeyaz, Eralp Tutar

{"title":"Fascicular/Purkinje Tissue Colocalized With Scar in Cardiomyopathy Patients Undergoing Ventricular Fibrillation Ablation.","authors":"Emir Baskovski, Timucin Altin, Omer Akyurek, Turkan Seda Tan, Mahmut EkremCunetoglu, Irem Muge Akbulut, Volkan Kozluca, Nail Burak Ozbeyaz, Eralp Tutar","doi":"10.1111/pace.15215","DOIUrl":"https://doi.org/10.1111/pace.15215","url":null,"abstract":"Background: Ventricular fibrillation (VF) is a poorly understood arrhythmia that is one of the main mechanisms of sudden cardiac death in patients with structural heart disease (SHD). Fascicular and Purkinje tissue (FPT) has been implicated in VF.Objective: In this study, we sought to analyze the involvement of FPT colocalized with the scar area of SHD. Additionally, we aimed to investigate outcomes of FPT and scar substrate ablation in SHD VF patients and compare outcomes with VT ablation patients.Methods: This is a retrospective observational study. Clinical and procedural data were collected.Results: Sixteen patients undergoing VF ablation were assigned to the VF group, and their outcomes were compared to those of 170 patients who underwent structural VT ablation. In 15 patients, FPT targets colocalized with low voltage area, LPs, and/or LAVAs. Septal Purkinje and left posterior fascicle were most commonly involved. Procedural metrics were similar with patients undergoing VT ablation. During median follow-up of 5.5 months (interquartile range [IQR]: 3.5-10), VF recurred in two patients.Conclusion: This study has shown frequent colocalization of FPT with electrophysiologic substrate (late potentials [LPs], low voltage area, etc.) in patients with SHD and VF. We have shown the feasibility of FTP and substrate ablation with good mid-term outcomes in a small group of patients. Larger studies are necessary for definitive evidence.","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144201358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical impact of nocturnal ventricular tachyarrythmias in electrical storm. 电风暴中夜间室性心动过速的临床影响。

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-11-01 Epub Date: 2022-09-28 DOI: 10.1111/pace.14592

Naomasa Suzuki, Sou Otsuki, Daisuke Izumi, Rie Akagawa, Yuta Sakaguchi, Takahiro Hakamata, Yasuhiro Ikami, Yuki Hasegawa, Nobue Yagihara, Kenichi Iijima, Masaomi Chinushi, Takayuki Inomata

引用次数: 0

Recall devices: Defects at initial visit and during remote monitoring supported follow-up. 召回设备:在初始访问和远程监控期间的缺陷支持后续。

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-11-01 Epub Date: 2022-07-09 DOI: 10.1111/pace.14552

Maciej Grymuza, Lidia Chmielewska-Michalak, Agnieszka Katarzyńska-Szymańska, Jacek Migaj, Maciej Lesiak, Przemysław Mitkowski

引用次数: 1

Interventricular septum angle obtained from cardiac computed tomography for origin differentiation of outflow tract ventricular arrhythmia between left and right. 心脏计算机断层对左、右流出道室间隔角的起源鉴别。

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-11-01 Epub Date: 2022-09-23 DOI: 10.1111/pace.14593

Xiaomei Zhu, Shumin Chen, Kefan Ma, Zenghong Chen, Chun Chen, Zhixin Jiang

{"title":"Interventricular septum angle obtained from cardiac computed tomography for origin differentiation of outflow tract ventricular arrhythmia between left and right.","authors":"Xiaomei Zhu, Shumin Chen, Kefan Ma, Zenghong Chen, Chun Chen, Zhixin Jiang","doi":"10.1111/pace.14593","DOIUrl":"https://doi.org/10.1111/pace.14593","url":null,"abstract":"Aims: Our objective was to explore whether the accuracy of the transitional zone index (TZI) for outflow tract ventricular arrhythmias (OT-VAs) origin is affected by cardiac rotation and the additive value of interventricular septum angle (IVSa) obtained from coronary computed tomography angiography (CCTA).Methods: Standard 12-lead ECGs of OT-VAs with inferior axis in consecutive patients undergoing both CCTA examination and successful ablation were retrospectively analyzed. The IVSa was defined as an angle between the long axis of IVS and sagittal axis of the body from CCTA.Results: 64 patients (31 men; mean age 54.2 ± 11.6 years) were enrolled. The OT-VAs exhibited right ventricular outflow tract origin in 46 (71.9%) patients and 36 (78.3%) were diagnosed correctly by TZI. The left ventricular outflow tract origin OT-VAs was observed in 18 (28.1%) patients and 16 (88.9%) were diagnosed correctly by TZI. The patients were then divided into TZI correct group (n = 52) and TZI incorrect group (n = 12). In the TZI incorrect group, 11/12 (91.7%) cases were R/S transition in lead V3 with the TZ score during premature ventricular contractions [2.8(2.5-3.4)], and the TZI between -1.5 and 0. The IVSa was significantly larger in the TZI incorrect group than correct group (52.0 ± 6.9° vs. 39.0 ± 6.1°; p < .0001). The IVSa ≥46° predicted TZI incorrect with 92% sensitivity, 94% specificity, and 94% accuracy.Conclusion: The IVSa is a novel cardiac rotation index that reliably improves TZI to differentiate the OT-VAs origin, especially for the OT-VAs with lead V3 R/S transition.","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"1279-1287"},"PeriodicalIF":1.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40356983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of very early recurrence of atrial fibrillation after cryoballoon ablation. 低温球囊消融后极早期房颤复发的影响。

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-11-01 Epub Date: 2022-09-01 DOI: 10.1111/pace.14583

Kohei Ukita, Yasuyuki Egami, Shodai Kawanami, Hiroki Sugae, Akito Kawamura, Hitoshi Nakamura, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga-Lee, Masamichi Yano, Masami Nishino, Jun Tanouchi

{"title":"Impact of very early recurrence of atrial fibrillation after cryoballoon ablation.","authors":"Kohei Ukita, Yasuyuki Egami, Shodai Kawanami, Hiroki Sugae, Akito Kawamura, Hitoshi Nakamura, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga-Lee, Masamichi Yano, Masami Nishino, Jun Tanouchi","doi":"10.1111/pace.14583","DOIUrl":"https://doi.org/10.1111/pace.14583","url":null,"abstract":"Background: Although much has been discussed about the early recurrence of atrial fibrillation (ERAF) after cryoballoon ablation (CBA), the clinical impact of very early recurrence of atrial fibrillation (VERAF) after CBA remains unclear. This study aimed to investigate the impact of VERAF after CBA.Methods: We enrolled 236 consecutive patients who underwent an initial CBA for paroxysmal atrial fibrillation between February 2017 and December 2020 in our hospital. These patients were categorized into three groups: VERAF group who experienced an initial recurrence of atrial tachyarrhythmia within 48 h after CBA, late-ERAF (LERAF) group who experienced an initial recurrence of atrial tachyarrhythmia between 48 h and 3 months after CBA, and non-ERAF (NERAF) group who did not experience a recurrence of atrial tachyarrhythmia within 3 months after CBA. We investigated the late recurrence of AF (LRAF, defined as recurrence of atrial tachyarrhythmia more than 3 months after CBA), and the incidence of non-pulmonary vein (PV) triggers in the patients who experienced a repeat ablation procedure due to LRAF.Results: VERAF group had a higher incidence of freedom from LRAF than LERAF group (p = 0.032) and a lower incidence of freedom from LRAF than NERAF group (p = 0.002). Moreover, VERAF group had the highest incidence of non-PV triggers at repeat ablation procedure among the three groups (p = 0.003).Conclusions: While ERAF was a predictor of LRAF, VERAF was less related to LRAF among the patients with ERAF after CBA. Furthermore, VERAF might be associated with non-PV triggers.","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"1323-1329"},"PeriodicalIF":1.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40608704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis. Amplatzer Amulet和Watchman 2.5治疗左心耳闭塞的安全性和有效性:一项系统综述和荟萃分析。

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-10-01 Epub Date: 2022-09-01 DOI: 10.1111/pace.14576

Ming-Zhen Zhu, Hao Song, Guang-Min Song, Xiao Bai

{"title":"Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.","authors":"Ming-Zhen Zhu, Hao Song, Guang-Min Song, Xiao Bai","doi":"10.1111/pace.14576","DOIUrl":"https://doi.org/10.1111/pace.14576","url":null,"abstract":"Background: Left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulation (OAC) to decrease the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF); however, certain complications remain a concern. Amplatzer Amulet and Watchman are the two most popular used devices for preventing stroke in patients with NVAF. We assessed the safety and efficacy of LAAO using the Amplatzer Amulet and Watchman.Methods: A meta-analysis was conducted to compare the safety and efficacy outcomes associated with the use of the Amplatzer Amulet and Watchman 2.5. The Newcastle-Ottawa Scale has been utilized to assess the quality of study.Results: The meta-analysis includes seven studies involving 2926 patients (1418 patients with an amulet and 1508 with a Watchman 2.5). Generally, adverse event rates for both systems were minimal. No significant differences between the two devices were found in safety (pericardial effusion, device embolization, and cardiac tamponade) or efficacy outcomes (death, TIA, stroke, major/minor bleeding, device leak, and thromboembolic events).Conclusions: The data suggest LAAO is a safe procedure, regardless of which device was used. LAAO devices generally have low complication rates. Outcomes were comparable between the two groups with no significant differences in their safety or efficacy.","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"1237-1247"},"PeriodicalIF":1.8,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40606024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Clinical impact of posterior wall isolation in catheter ablation for persistent atrial fibrillation: A systematic review and meta-analysis. 后壁隔离对持续性房颤导管消融的临床影响：一项系统回顾和荟萃分析。

Pacing and clinical electrophysiology : PACE Pub Date : 2022-10-01 Epub Date: 2022-09-20 DOI: 10.1111/pace.14591

Xiaohua Liu, Xiaofei Gao, Lian Chen, Lishui Shen, Meijun Liu, Yizhou Xu

{"title":"Clinical impact of posterior wall isolation in catheter ablation for persistent atrial fibrillation: A systematic review and meta-analysis.","authors":"Xiaohua Liu, Xiaofei Gao, Lian Chen, Lishui Shen, Meijun Liu, Yizhou Xu","doi":"10.1111/pace.14591","DOIUrl":"10.1111/pace.14591","url":null,"abstract":"Background: The clinical outcomes of pulmonary venous isolation alone for persistent atrial fibrillation (PerAF) remain unclear. Adjuvant posterior wall isolation (PWI) has become a potential supplementary strategy for improving the outcome of PerAF ablation. This meta-analysis aimed to evaluate the effect of PWI added to catheter ablation for PerAF.Methods: PubMed, EMBASE, and Cochrane Library databases were searched for studies comparing the outcomes of PerAF ablation with and without PWI. The efficacy outcomes were recurrence of atrial arrhythmia (AA), atrial fibrillation (AF), and atrial tachycardia (AT), and the safety outcome was adverse events.Results: In total, eight studies with 1428 patients were included in the pooled analyses. The results showed that PWI significantly reduced the recurrence of AA (RR = 0.69, 95% CI = 0.55-0.87, p = .002, I2 = 63%) and AF (RR = 0.57, 95% CI = 0.40-0.80, p = .001, I2 = 70%). AT recurrence (RR = 0.92, 95% CI = 0.67-1.27, p = .63, I2 = 42%) and adverse events (RR = 1.11, 95% CI = 0.67-1.84, p = .70, I2 = 0%) were comparable between the two groups. In the sub-analyses, the efficacy of PWI in reducing AA recurrence was consistent in patients who underwent cryoablation or debulking ablation.Conclusion: PWI effectively decreased AA recurrence after PerAF ablation without increasing the risk of AT or procedure-related complications. However, more randomized studies are needed to confirm these results.","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"1268-1276"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33451681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Why is the patient still symptomatic after myectomy for HCM! 为什么患者在子宫肌瘤切除术后仍有症状!

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-10-01 Epub Date: 2022-07-25 DOI: 10.1111/pace.14567

Ramil Goel, Iain Thompson, William M Miles

引用次数: 0

Pulsed electrical field in arrhythmia treatment: Current status and future directions. 脉冲电场在心律失常治疗中的应用现状及未来发展方向。

IF 1.8

Pacing and clinical electrophysiology : PACE Pub Date : 2022-10-01 Epub Date: 2022-09-08 DOI: 10.1111/pace.14586

Jie Qiu, Lan Lan, Yan Wang

引用次数: 2

An unexpected route of temporary pacing lead. 临时起搏导线的意外路线。